Skip to main content
Navigate back to homepage
Open search bar.
Open main navigation menu

Main navigation

  • Study
    UCL Portico statue
    Study at UCL

    Being a student at UCL is about so much more than just acquiring knowledge. Studying here gives you the opportunity to realise your potential as an individual, and the skills and tools to thrive.

    • Undergraduate courses
    • Graduate courses
    • Short courses
    • Study abroad
    • Centre for Languages & International Education
  • Research
    Tree-of-Life-MehmetDavrandi-UCL-EastmanDentalInstitute-042_2017-18-800x500-withborder (1)
    Research at UCL

    Find out more about what makes UCL research world-leading, how to access UCL expertise, and teams in the Office of the Vice-Provost (Research, Innovation and Global Engagement).

    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage
    UCL Print room
    Engage with UCL

    Discover the many ways you can connect with UCL, and how we work with industry, government and not-for-profit organisations to tackle tough challenges.

    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Public Policy
    • Schools and priority groups
    • Visit us
  • About
    UCL welcome quad
    About UCL

    Founded in 1826 in the heart of London, UCL is London's leading multidisciplinary university, with more than 16,000 staff and 50,000 students from 150 different countries.

    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
  • Active parent page: Brain Sciences
    • Study
    • Research
    • About the Faculty
    • Institutes and Divisions
    • Active parent page: News and Events
    • Contact

Repurposed cardiac sodium channel blocker brings significant benefit for patients with a rare neuromuscular disease

Breadcrumb trail

  • Brain Sciences
  • News and Events

Faculty menu

  • Current page: Faculty news
  • Events

An international multi-centred trial published in the leading medical journal JAMA (The Journal of the American Medical Association) this week, demonstrates a significant treatment benefit using the repurposed cardiac drug, mexiletine, in a genetically stratified cohort of patients with the rare genetic neurological disorder, non-dystrophic myotonia. Professor Michael Hanna, Director of the MRC Centre for Neuromuscular Diseases led the UCL team including MRC clinical training fellow Dr Dipa Raja Rayan as the top recruiting site in this international trial. 

Patients with non-dystrophic myotonia have genetic mutations that result in increased opening of the skeletal muscle voltage-gated sodium channel (NaV1.4) leading to membrane hyperexcitability and manifesting as significant clinical myotonia (stiffness from impaired muscle relaxation). The disorder is estimated to affect approximately 1 in 100,000 people causing debilitating stiffness, pain, weakness and fatigue. It can have a significant impact on patients’ ability to work and quality of life, therefore finding an effective treatment is important.  Mexiletine, is a class 1b anti-arrhythmic drug that acts by blocking sodium channels in the heart and skeletal muscle but has been superseded by more modern drugs for the treatment of arrhythmias. 

The double-blind randomised placebo-controlled experimental medicine Phase II study was carried out in 59 genetically stratified  patients at seven neuromuscular centres in four countries, the largest number of which were recruited by Professor Hanna’s group in the UK. The study clearly demonstrated that mexiletine significantly reduced patient-reported symptoms of stiffness, pain, weakness and fatigue as well as electrically measured myotonia and quantitative grip myotonia in patients compared to placebo.

The study demonstrates that it is possible to perform robust phase II experimental medicine clinical trials with impact in rare diseases through leading international collaboration and effective rare disease networks.

Full study: JAMA mexiletine study

Editorial: JAMA Editorial

JAMA homepage: http://jama.jamanetwork.com/journal.aspx

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources

UCL social media menu

  • Link to Soundcloud
  • Link to Flickr
  • Link to TikTok
  • Link to Youtube
  • Link to Instagram
  • Link to Facebook
  • Link to Twitter

University College London, Gower Street, London, WC1E 6BT

Tel: +44 (0) 20 7679 2000

© 2025 UCL

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in